| Financial Year |
March 31 2023 |
| Monetary Funds |
504,546,972.09 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
1,845,275,289.62 |
| Advances to Suppliers |
58,403,979.75 |
| Other Receivables |
290,576,558.39 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
833,474,079.50 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
12,828,474.10 |
| Total Current Assets |
4,030,944,382.14 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,080,466,810.03 |
| Investment Properties |
24,770,059.70 |
| Fixed Assetes |
794,556,494.93 |
| Under-construction Projects |
207,742,308.44 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
5,800,897.21 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
186,029,608.96 |
| R&D expenses |
126,606,481.86 |
| Goodwill |
20,583,856.73 |
| Long-Term Deferred and Prepaid Expenses |
22,796,343.59 |
| Deferred Income Tax Assets |
84,964,287.37 |
| Other Non-Current Assets |
83,491,576.34 |
| Sub-Total of Non-Current Assets |
3,054,991,557.78 |
| Total Assets |
7,085,935,939.92 |
| Short-Term Loans |
1,446,618,784.99 |
| Trading Financial liabilities |
-- |
| Notes Payable |
78,000,000.00 |
| Accounts Payable |
587,688,046.85 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
31,873,461.13 |
| Taxes Payable |
65,729,543.75 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
349,209,574.81 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
45,569,161.03 |
| Other Current Liabilities |
112,632,123.38 |
| Sub-Total of Current Liabilities |
2,821,423,475.59 |
| Long-term Loans |
150,169,583.33 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
18,177,715.24 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
27,096,613.43 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
275,760,031.88 |
| Total Liabilities |
3,097,183,507.47 |
| Paid-In Capital(Or Share Stock) |
1,411,200,000.00 |
| Capital Surplus |
140,957,528.42 |
| Surplus Reserve |
368,656,467.57 |
| LESS:Treasury Stock |
200,206,691.53 |
| Undistributed Profits |
2,266,277,434.14 |
| Minority Stockholder's Interest |
1,816,656.74 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,986,935,775.71 |
| Owner's Equity（Stockholder's Equity） |
3,988,752,432.45 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,085,935,939.92 |
